Prognostic and Clinical Value of CD44 and CD133 in Esophageal Cancer: A Systematic Review and Meta-analysis.

In conclusion, CD44 overexpression was associated with a 5-year overall survival rate and thus this biomarker can be a suitable prognostic tool in esophageal cancer. PMID: 32372624 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32372624?dopt=Abstract

Source: Iranian Journal of Allergy, Asthma and Immunology - April 15, 2020 Category: Allergy & Immunology Authors: Kamil Mohammed Al-Mosawi A, Cheshomi H, Hosseinzadeh A, M Matin M Tags: Iran J Allergy Asthma Immunol Source Type: research